Gotham Asset Management LLC Sells 5,519 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Gotham Asset Management LLC lowered its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 19.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 22,322 shares of the biotechnology company's stock after selling 5,519 shares during the quarter. Gotham Asset Management LLC's holdings in Axon Enterprise were worth $13,266,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in AXON. Ground Swell Capital LLC acquired a new position in Axon Enterprise in the fourth quarter valued at about $322,000. Ellevest Inc. acquired a new position in shares of Axon Enterprise during the fourth quarter worth about $295,000. Ensign Peak Advisors Inc grew its stake in shares of Axon Enterprise by 11.5% during the 4th quarter. Ensign Peak Advisors Inc now owns 32,965 shares of the biotechnology company's stock worth $19,592,000 after acquiring an additional 3,402 shares in the last quarter. Ethic Inc. increased its stake in Axon Enterprise by 12.0% in the 4th quarter. Ethic Inc. now owns 2,848 shares of the biotechnology company's stock valued at $1,693,000 after buying an additional 306 shares during the last quarter. Finally, FORA Capital LLC bought a new stake in Axon Enterprise during the fourth quarter worth about $9,517,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, President Joshua Isner sold 9,000 shares of the stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $683.31, for a total transaction of $6,149,790.00. Following the completion of the sale, the president now owns 308,714 shares in the company, valued at approximately $210,947,363.34. This trade represents a 2.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Jeri Williams sold 307 shares of the business's stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the sale, the director now owns 1,627 shares in the company, valued at $899,275.44. This represents a 15.87% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 19,964 shares of company stock valued at $12,189,275. Corporate insiders own 4.40% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the stock. Barclays upped their price target on shares of Axon Enterprise from $726.00 to $735.00 and gave the stock an "overweight" rating in a research report on Friday. JMP Securities reaffirmed an "outperform" rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Craig Hallum cut shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. Northcoast Research downgraded Axon Enterprise from a "buy" rating to a "neutral" rating in a research note on Wednesday, February 19th. Finally, The Goldman Sachs Group upped their target price on Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a research note on Monday, January 27th. One analyst has rated the stock with a sell rating, one has issued a hold rating and ten have issued a buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $640.91.

Axon Enterprise Trading Up 4.6%

AXON stock traded up $31.67 during trading on Tuesday, hitting $724.77. The company had a trading volume of 868,238 shares, compared to its average volume of 767,097. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a one year low of $273.52 and a one year high of $732.17. The business has a 50-day moving average of $572.18 and a 200-day moving average of $588.52. The stock has a market cap of $56.42 billion, a PE ratio of 187.28, a PEG ratio of 5.17 and a beta of 1.24.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.34 by $0.07. The firm had revenue of $603.63 million for the quarter, compared to the consensus estimate of $585.67 million. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. The business's revenue for the quarter was up 31.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.15 EPS. Research analysts predict that Axon Enterprise, Inc. will post 5.8 earnings per share for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.